Skip to search formSkip to main contentSkip to account menu

BIN1 protein

Known as: BIN1, Amphiphysin II, Bridging Integrator 1 
Encoded as ten alternate splicing variant isoforms by human BIN1 Gene, ubiquitously expressed nucleocytoplasmic adaptor protein Bridging Integrator 1… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
The mechanisms driving pathological beta‐amyloid (Aβ) generation in late‐onset Alzheimer's disease (AD) are unclear. Two late… 
Highly Cited
2016
Highly Cited
2016
Genome-wide association studies have identified BIN1 within the second most significant susceptibility locus in late-onset… 
Highly Cited
2012
Highly Cited
2012
Cisplatin is the most important and efficacious chemotherapeutic agent for the treatment of advanced gastric cancer. Cisplatin… 
Highly Cited
2011
Highly Cited
2011
Myotubular myopathy and centronuclear myopathies (CNM) are congenital myopathies characterized by generalized muscle weakness and… 
Highly Cited
2011
Highly Cited
2011
c-MYC promotes cisplatin resistance by enabling the increased activity of a DNA repair enzyme. Losing Your Inhibitions The… 
Highly Cited
2009
Highly Cited
2009
The mechanisms underlying white matter changes in psychiatric disease are not known. We aimed to characterise the differential… 
Highly Cited
1999
Highly Cited
1999
Several SH3-domain-containing proteins have been implicated in endocytosis by virtue of their interactions with dynamin; however… 
Highly Cited
1997
Highly Cited
1997
Amphiphysin (amphiphysin I), a dominant autoantigen in paraneoplastic Stiff-man syndrome, is a neuronal protein highly… 
Highly Cited
1997
Highly Cited
1997
Amphiphysin is a nerve terminal-enriched protein thought to function in synaptic vesicle endocytosis, in part through Src… 
Highly Cited
1997
Highly Cited
1997
BIN1 is a putative tumor suppressor that was identified through its interaction with the MYC oncoprotein. To begin to identify…